Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C

Digestive and Liver Disease

Volumn 45, Issue 10, 2013, Pages 840-843

  Stasi, Cristina ^a   Arena, Umberto ^a   Zignego, Anna Linda ^a   Corti, Giampaolo ^a   Monti, Monica ^a   Triboli, Elisa ^a   Pellegrini, Elena ^a   Renzo, Sara ^a   Leoncini, Luisa ^a   Marra, Fabio ^a   Laffi, Giacomo ^a   Milani, Stefano ^a   Pinzani, Massimo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Antiviral treatment; Chronic hepatitis C; Fibrosis; Liver stiffness; Sustained virological response

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; RIGIDITY;

ANTIVIRAL TREATMENT; AR; ATTRIBUTABLE RISK; CHC; CHRONIC HEPATITIS C; CHRONIC LIVER DISEASES; CLD; FIBROSIS; HCV; HEPATITIS C VIRUS; INTERQUARTILE RANGE; IQR; LIVER STIFFNESS; NR; NULL RESPONSE; RELATIVE RISK; RR; SOC; STANDARD OF CARE; SUSTAINED VIROLOGIC RESPONSE; SUSTAINED VIROLOGICAL RESPONSE; SVR; TE; TRANSIENT ELASTOGRAPHY;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKINS; LIVER; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD;

EID: 84883797896     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.03.023     Document Type: Article

References (21)

1. WHO. Fact sheet N°164, June 2011. http://goo.gl/5m3sY.
2. European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatitis C. Journal of Hepatology 2011, 55:245-264.
3. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.
4. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
5. Arena U., Vizzutti F., Abraldes J., et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008, 57:1288-1293.
6. Reiberger T., Rutter K., Ferlitsch A., et al. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clinical Gastroenterology and Hepatology 2011, 9:602-608. e1.
7. Ogawa E., Furusyo N., Toyoda K., et al. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Research 2009, 83:127-134.
8. Arima Y., Kawabe N., Hashimoto S., et al. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatology Research 2010, 40:383-392.
9. Macías J., del Valle J., Rivero A., et al. Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin. Journal of Antimicrobial Chemotherapy 2010, 65:2204-2211.
10. Wang J.H., Changchien C.S., Hung C.H., et al. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: longitudinal study using FibroScan. Journal of Gastroenterology and Hepatology 2010, 25:964-969.
11. Martinez S.M., Foucher J., Combis J.M., et al. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy. PLoS ONE 2012, 7:e47715.
12. Guido M., Rugge M. Liver fibrosis: natural history may be affected by the biopsy sample. Gut 2004, 53:1878.
13. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994, 20:15-20.
14. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
15. Stasi C., Arena U., Vizzutti F., et al. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool. Digestive and Liver Disease 2009, 41:863-866.
16. Toccacelli F., Laghi V., Capurso L., et al. Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon. Journal of Viral Hepatitis 2003, 10:126-133.
17. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology 2003, 29:1705-1713.
18. Foucher J., Castera L., Bernard P.H., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. European Journal of Gastroenterology and Hepatology 2006, 18:411-412.
19. Dalgard O., Bjøro K., Hellum K.B., et al. Treatment with pegylated interferon and ribavirin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology 2004, 40:1260-1265.
20. Bourlière M., Ouzan D., Rosenheim M., et al. Peg interferon alfa 2a plus ribavirin for chronic hepatitis C in a real life setting: the Hepatys French cohort (2003-2007). Antiviral Therapy 2012, 17:101-110.
21. Andersen E.S., Moessner B.K., Christensen P.B., et al. Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C. European Journal of Gastroenterology and Hepatology 2011, 23:41-44.